Current Treatment Paradigms for the Management of Patients with Brain Metastases
- 1 November 2005
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 57 (5), S4-66
- https://doi.org/10.1227/01.neu.0000182739.84734.6e
Abstract
BRAIN METASTASES CONTINUE to be a major and growing challenge in oncology, but recent advances in surgery, radiosurgery, and chemotherapy have broadened the number of treatment options. Current approaches to the management of brain metastases focus on individualizing patient care based on factors including the Karnofsky Performance Status, the tumor histology, the number of metastases, and the status of the systemic disease. A number of treatment approaches have been shown to be effective for brain metastases, including surgery; radiosurgery; whole-brain radiotherapy; and, more recently, chemotherapy. The use of adjuvant whole-brain radiotherapy with local therapies, such as surgery or radiosurgery, along with newer chemotherapy options, such as targeted biological agents, temozolomide, and implantable 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Gliadel® wafers, are at the forefront of recent advances in the treatment of patients with brain metastases that may provide longer survival and improved quality of life. Although there is no current standard treatment, some general guidelines are recommended for single metastases, oligometastases (two to three brain metastases), and multiple (four or more) brain metastases, and for new or recurrent disease. With advances in systemic therapy for cancer, the treatment of brain metastases is becoming an increasingly important determinant of the length of survival and quality of life for cancer patients.Keywords
This publication has 85 references indexed in Scilit:
- Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II StudyJournal of Clinical Oncology, 2004
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Radiosurgery as palliation for brain metastases: a retrospective review of 72 patients harboring multiple lesions at presentationJournal of Neurosurgery, 2002
- Risk factors affecting survival after brain metastases from non—small cell lung carcinoma: a follow-up study of 70 patientsJournal of Neurosurgery, 2001
- Surgery versus radiosurgery in the treatment of brain metastasisJournal of Neurosurgery, 1996
- Surgical resection of brain metastases from lung cancerActa Neurochirurgica, 1996
- A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasisInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Reoperation for recurrent metastatic brain tumorsJournal of Neurosurgery, 1995
- The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancerCancer, 1995
- Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain MetastasesJNCI Journal of the National Cancer Institute, 1995